Figure 1. Biosynthesis of DGGGP, a key intermediate for archaeal membrane lipids. Key: G-1-P, (S)-glyceryl phosphate; GGGPS, (S)-
GGGP synthase; DGGGPS, DGGGP synthase.
family of prenyltransferases.9-12 As shown in Figure 1, the
biogenesis of the core structure of the archaeal membrane
lipids starts with the prenyl transfer reaction catalyzed by
(S)-3-O-geranylgeranylglyceryl phosphate [(S)-GGGP] syn-
thase, which selectively uses (S)-glyceryl phosphate as the
prenyl acceptor (Figure 1). Then, the product is utilized as
the presumed acceptor substrate for the biosynthesis of (S)-
2,3-di-O-geranylgeranylglyceryl phosphate (DGGGP), an
advanced intermediate of archaeal membrane lipids.13
To date, only an enzyme-assisted synthesis of (S)-GGGP
has been reported.11 An enantiospecific chemical synthesis
of both individual enantiomers of GGGP was required to
validate this biosynthetic hypothesis, in part because of the
acid-sensitive geranylgeranyl group of GGGP. To fully
characterize the substrate selectivity of DGGGP synthase
(DGGGPS), we developed a mild and effective route to the
two GGGP enantiomers. The instability of GGGP indeed
posed significant challenges, and the biological results with
the enantiomers were unexpected.
phorylation of the primary hydroxyl, we first tried a strategy
involving protection of the secondary hydroxyl as a silyl
ether. Thus, both hydroxyl groups of diol 4 were protected
as TBS ethers (TBSCl, imidazole, anhydrous DMF).15,16
Subsequently, the more labile primary TBS ether was
selectively removed at room temperature by using HF‚Py
(HF‚Py/Py/THF ) 1:2:5). Unfortunately, phosphorylation of
the primary alcohol under standard conditions (dimeth-
ylphosphoryl chloride, t-BuOK, CH2Cl2)15,16 failed to give
the desired product because of the lability of the polyene
system.
A second strategy proved more successful. The use of the
trimethyl phosphite/carbon tetrabromide oxidative phospho-
rylation method17 was deemed sufficiently mild to permit
phosphorylation without damage to the geranylgeranyl
moiety. Treatment of diol 4 with 1.1 equiv of CBr4 and 1.2
equiv of P(OMe)3 gave selective phosphorylation of the
primary alcohol to give the protected phosphate 7. Essentially
no bisphosphate product was detected.
The synthesis of (S)-GGGP (8) is summarized in Scheme
1. Treatment of the (2E,6E,10E)-geranylgeraniol 1 with Ph3P/
CBr4 at 25 °C afforded geranylgeranyl bromide 2.14 Next,
(S)-solketal was alkylated with geranylgeranyl bromide by
using KH as base, to give ether 3 in 73% yield.11 The
reported HCl/THF method to remove the acetonide13 resulted
in a complex mixture containing the desired product in low
yield. The desired diol 4 was thus prepared in 75% yield
using p-TsOH in methanol.15,16 To obtain selective phos-
The next challenge in this synthesis was liberation of the
free phosphate monoester from the protected triester. We first
tried TMSBr, a standard deprotecting reagent for removal
of methyl and ethyl groups in the synthesis of acyl-migration-
prone lysophosphatidic acid derivatives.15,16 However, GGGP
did not survive this strong Lewis acid. By using a solution
of TMSBr in 2,4,6-trimethylpyridine (sym-collidine),18-20 we
obtained the desired monophosphate in the acidic form.
Titration with 1 N aq NaOH afforded (S)-GGGP (8) as the
stabilized sodium salt.
(9) Poulter, C. D. In Biochemistry of Cell Walls and Membranes in Fungi;
Kuhn, P. J., Trinci, A. P. J., Jung, M. J., Goosey, M. W., Copping, L. G.,
Eds.; Springer-Verlag: Berlin, Heidelberg, 1990; pp 169-188.
(10) Poulter, C. D. In Biosynthesis of Isopreniod compounds; Rilling,
H. C., Porter, J. W., Spurgeon, S. L., Eds.; Wiley: New York, 1981; Vol.
I, pp 161-224.
To determine the enantioselectivity of DGGGPS, both the
enantiomers (S)-GGGP (8) and (R)-GGGP (12) were re-
(16) Xu, Y.; Qian, L.; Prestwich, G. D. J. Org. Chem. 2003, 68, 5320-
5330.
(11) Zhang, D.; Poulter, C. D. J. Am. Chem. Soc. 1993, 115, 1270-
1277.
(17) Oza, V. B.; Corcoran, R. C. J. Org. Chem. 1995, 60, 3680-3684.
(18) Cermak, D. M.; Wiemer, D. F.; Lewis, K.; Hohl, R. J. Bioorg. Med.
Chem. 2000, 8, 2729-2737.
(12) Ohnuma, S.-i.; Suzuki, M.; Nishino, T. J. Biol. Chem. 1994, 269,
14792-14797.
(13) Hemmi, H.; Shibuya, K.; Takahashi, Y.; Nakayama, T.; Nishino,
T. J. Biol. Chem. 2004, 279, 50197-50203.
(19) Macchia, M.; Jannitti, N.; Gervasi, G.; Danesi, R. J. Med. Chem.
1996, 39, 1352-1356.
(14) Tokumasu, M. A. H.; Hiraga, Y.; Kojima, S.; Ohkta, K. J. Chem.
Soc., Perkin Trans. 1 1999, 489-496.
(20) Magnin, D. R.; Biller, S. A.; Dickson, J. K., Jr.; Logan, J. V.;
Lawrence, R. M.; Chen, Y.; Sulsky, R. B.; Ciosek, C. P., Jr.; Harrity, T.
W.; Jolibois, K. G.; et al. J. Med. Chem. 1995, 38, 2596-2605.
(15) Xu, Y.; Prestwich, G. D. J. Org. Chem. 2002, 67, 7158-7161.
944
Org. Lett., Vol. 8, No. 5, 2006